Medprin Historical Cash Flow
| 301033 Stock | 44.99 0.72 1.58% |
Analysis of Medprin Regenerative cash flow over time is an excellent tool to project Medprin Regenerative future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Free Cash Flow of 81.6 M or Change In Working Capital of 43.5 M as it is a great indicator of Medprin Regenerative ability to facilitate future growth, repay debt on time or pay out dividends.
Medprin |
About Medprin Cash Flow Analysis
The Cash Flow Statement is a financial statement that shows how changes in Medprin balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Medprin's non-liquid assets can be easily converted into cash.
Medprin Regenerative Cash Flow Chart
Begin Period Cash Flow
The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.Capital Expenditures
Capital Expenditures are funds used by Medprin Regenerative to acquire physical assets such as property, industrial buildings or equipment. This type of outlay is used by management to increase the scope of Medprin Regenerative operations. These expenditures can include everything from repairing an office equipment, building a brand new facility, or writing new software.Net Income
Net income is one of the most important fundamental items in finance. It plays a large role in Medprin Regenerative financial statement analysis. It represents the amount of money remaining after all of Medprin Regenerative Medical operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.Most accounts from Medprin Regenerative's cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into Medprin Regenerative current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Medprin Regenerative Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. At present, Medprin Regenerative's Change To Inventory is projected to increase significantly based on the last few years of reporting. The current year's Free Cash Flow is expected to grow to about 81.6 M, whereas Investments are forecasted to decline to (98.9 M).
Medprin Regenerative cash flow statement Correlations
Click cells to compare fundamentals
Medprin Regenerative Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Medprin Regenerative cash flow statement Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Change To Inventory | (1.0M) | (4.6M) | (8.3M) | 3.2M | 3.7M | 3.8M | |
| Investments | (91.8M) | (314.9M) | 18.6M | (81.9M) | (94.2M) | (98.9M) | |
| Change In Cash | (16.7M) | (1.3M) | 34.6M | (18.1M) | (20.8M) | (21.8M) | |
| Free Cash Flow | (27.7M) | (86.2M) | (87.6M) | 67.6M | 77.7M | 81.6M | |
| Change In Working Capital | (5.1M) | 18.1M | 5.1M | 36.0M | 41.4M | 43.5M | |
| Begin Period Cash Flow | 28.2M | 11.5M | 10.2M | 44.8M | 40.3M | 29.4M | |
| Depreciation | 5.0M | 8.2M | 15.2M | 25.3M | 29.1M | 30.6M | |
| Other Non Cash Items | 1.7M | 2.4M | (594.0K) | 3.4M | 3.9M | 4.1M | |
| Capital Expenditures | 61.6M | 152.7M | 136.0M | 40.1M | 46.1M | 43.8M | |
| Total Cash From Operating Activities | 33.9M | 66.5M | 48.3M | 107.7M | 123.8M | 63.3M | |
| Net Income | 37.0M | 44.7M | 35.9M | 40.9M | 47.0M | 41.0M | |
| End Period Cash Flow | 11.5M | 10.2M | 44.8M | 26.7M | 30.7M | 26.7M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Medprin Stock
The Cash Flow Statement is a financial statement that shows how changes in Medprin balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Medprin's non-liquid assets can be easily converted into cash.